Introducing the clone of Lantus. Discover another …

Identical is not identical. Unless it's interchangeable. Introducing the clone of lantus . Discover another way to say lantus . October 2015. Dear Valued Customer, Sanofi Diabetes is pleased to announce the launch of OPTISULIN, the clone of lantus . OPTISULIN (insulin glargine) is identical to lantus (insulin glargine) in all aspects, except for the name and price. OPTISULIN (Insulin glargine) is a long acting, basal insulin analogue produced by recombinant DNA technology using Escherichia coli (K12 strains). OPTISULIN is equipotent to human insulin and is indicated for the treatment of adults, adolescents and children 6 years and older with diabetes mellitus, where treatment of insulin is required. OPTISULIN is given subcutaneously once daily. The desired blood glucose levels as well as the doses and the timing of any antidiabetic medication, including OPTISULIN, must be determined and adjusted individually.

Identical is not identical. Unless it’s interchangeable. Discover another way to say Lantus. SCHEDULING STATUS: S3 PROPRIETARY NAME AND DOSAGE FORM: LANTUS® solution for injection.COMPOSITION: Each ml of the solution for injection contains 3.64 mg of the active ingredient insulin glargine, corresponding to 100 units (u) human …

Tags:

  Name, Scheduling, Status, Another, Proprietary, Discover, Introducing, Clones, Scheduling status, S3 proprietary name, Introducing the clone of lantus, Lantus, Discover another

Information

Related search queries